In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
NCT00354536
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
GSK716155 subcutaneous injections
BIOLOGICAL:
placebo injection
Sponsor
GlaxoSmithKline